Functional Outcomes After Decompressive Surgery in Patients with Malignant Space-Occupying Cerebellar Infarction
Abstract
:1. Introduction
2. Methods
2.1. Data Sources and Patient Selection
2.2. Baseline Demographic, Clinical and Radiological Characteristics
2.3. Endpoints
2.4. Statistical Analysis
3. Results
3.1. Survival
3.2. Functional Outcome
3.3. Complications
3.4. Comparison of Patients with Good and Poor Functional Outcomes
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Conflicts of Interest
Abbreviations
CT | computed tomography |
EVD | external ventricular drain |
EVT | endovascular treatment |
MRI | magnetic resonance imaging |
mRS | modified Rankin Scale |
NIHSS | National Institutes of Health Stroke Scale |
TOAST | Trial of Org 10172 in Acute Stroke Treatment |
tPA | tissue plasminogen activator |
References
- Edlow, J.A.; Newman-Toker, D.E.; Savitz, S.I. Diagnosis and initial management of cerebellar infarction. Lancet Neurol. 2008, 7, 951–964. [Google Scholar] [CrossRef] [PubMed]
- Dashyan, V.G.; Khodykin, E.A.; Nikitin, A.S.; Godkov, I.M.; Khovrin, D.V.; Sosnovsky, E.A.; Asratyan, S.A.; Sytnik, A.V.; Ochkin, S.S.; Akhmedzhanova, N.R. Zlokachestvennyĭ infarkt mozzhechka: Klinicheskoe techenie i khirurgicheskoe lechenie [Malignant cerebellar infarction: Clinical course and surgical treatment]. S.S. Korsakov J. Neurol. Psychiatry 2019, 119, 75–83. (In Russian) [Google Scholar] [CrossRef] [PubMed]
- Baki, E.; Baumgart, L.; Kehl, V.; Hess, F.; Wolff, A.W.; Wagner, A.; Hernandez Petzsche, M.R.; Boeckh-Behrens, T.; Hemmer, B.; Meyer, B.; et al. Predictors of malignant swelling in space-occupying cerebellar infarction. Stroke Vasc. Neurol. 2024, svn-2024-003360. [Google Scholar] [CrossRef] [PubMed]
- Sims, J.R.; Gharai, L.R.; Schaefer, P.W.; Vangel, M.; Rosenthal, E.S.; Lev, M.H.; Schwamm, L.H. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 2009, 72, 2104–2110. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Won, S.Y.; Hernández-Durán, S.; Behmanesh, B.; Bernstock, J.D.; Czabanka, M.; Dinc, N.; Dubinski, D.; Freiman, T.M.; Günther, A.; Hellmuth, K.; et al. Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts. JAMA Neurol. 2024, 81, 384–393. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Pfefferkorn, T.; Eppinger, U.; Linn, J.; Birnbaum, T.; Herzog, J.; Straube, A.; Dichgans, M.; Grau, S. Long-term outcome after suboccipital decompressive craniectomy for malignant cerebellar infarction. Stroke 2009, 40, 3045–3050. [Google Scholar] [CrossRef] [PubMed]
- Jüttler, E.; Schweickert, S.; Ringleb, P.A.; Huttner, H.B.; Köhrmann, M.; Aschoff, A. Long-term outcome after surgical treatment for space-occupying cerebellar infarction: Experience in 56 patients. Stroke 2009, 40, 3060–3066. [Google Scholar] [CrossRef] [PubMed]
- Tsitsopoulos, P.P.; Tobieson, L.; Enblad, P.; Marklund, N. Surgical treatment of patients with unilateral cerebellar infarcts: Clinical outcome and prognostic factors. Acta Neurochir. 2011, 153, 2075–2083. [Google Scholar] [CrossRef] [PubMed]
- Rangaraju, S.; Haussen, D.; Nogueira, R.G.; Nahab, F.; Frankel, M. Comparison of 3-Month Stroke Disability and Quality of Life across Modified Rankin Scale Categories. Interv. Neurol. 2017, 6, 36–41. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Johnston, K.C.; Li, J.Y.; Lyden, P.D.; Hanson, S.K.; Feasby, T.E.; Adams, R.J.; Faught, R.E., Jr.; Haley, E.C., Jr.; RANTTAS Investigators. Medical and neurological complications of ischemic stroke: Experience from the RANTTAS trial. Stroke 1998, 29, 447–453. [Google Scholar] [CrossRef] [PubMed]
- Rollo, E.; Brunetti, V.; Scala, I.; Callea, A.; Marotta, J.; Vollono, C.; Frisullo, G.; Broccolini, A.; Calabresi, P.; Della Marca, G. Impact of delirium on the outcome of stroke: A prospective, observational, cohort study. J. Neurol. 2022, 269, 6467–6475. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Oldenbeuving, A.W.; de Kort, P.L.; Jansen, B.P.; Algra, A.; Kappelle, L.J.; Roks, G. Delirium in the acute phase after stroke: Incidence, risk factors, and outcome. Neurology 2011, 76, 993–999. [Google Scholar] [CrossRef] [PubMed]
Total Cohort (n = 58) | Poor Functional Outcome, mRS 4–6 (n = 34) | Good Functional Outcome, mRS 0–3 (n = 24) | Odds Ratio | 95% CI for OR | p-Value | |
---|---|---|---|---|---|---|
Demographic characteristics | ||||||
Age (years), mean (±SD) | 61.2 (±15.4) | 60.3 (±17.3) | 62.5 (±12.6) | 0.991 | (0.957, 1.026) | 0.594 |
Female, n (%) | 21 (36.2%) | 15 (44.1%) | 6 (25.0%) | 2.368 | (0.753, 7.446) | 0.140 |
Premorbid status | ||||||
Premorbid mRS, median (range) | 1 (0–4) | 1 (0–4) | 0 (0–2) | 2.011 | (1.165, 3.468) | 0.012 |
Vascular risk factors, n (%) | ||||||
Arterial hypertension | 38 (65.5%) | 20 (58.8%) | 18 (75.0%) | 0.476 | (0.151, 1.502) | 0.206 |
Diabetes mellitus | 18 (31.0%) | 11 (32.4%) | 7 (29.2%) | 1.161 | (0.373, 3.618) | 0.796 |
Coronary heart disease | 15 (25.9%) | 10 (29.4%) | 5 (20.8%) | 1.583 | (0.462, 5.421) | 0.464 |
Hypercholesterolemia | 18 (31.0%) | 9 (26.5%) | 9 (37.5%) | 0.600 | (0.195, 1.846) | 0.373 |
Acute stroke severity index | ||||||
NIHSS on admission, median (range) | 8 (0–38) | 14 (0–38) | 5 (0–34) | 1.106 | (1.035, 1.181) | 0.003 |
Cause of infarction according to TOAST criteria, n (%) | ||||||
Large-artery atherosclerosis | 10 (17.2%) | 5 (14.7%) | 5 (20.8%) | 0.655 | (0.167, 2.573) | 0.545 |
Cardioembolism | 22 (37.9%) | 13 (38.2%) | 9 (37.5%) | 1.032 | (0.351, 3.031) | 0.955 |
Small-vessel occlusion | 0 | |||||
Stroke of other determined etiology | 11 (19.0%) | 8 (23.5%) | 3 (12.5%) | 2.154 | (0.507, 9.147) | 0.298 |
Stroke of undetermined etiology | 15 (25.9%) | 8 (23.5%) | 7 (29.2%) | 0.747 | (0.229, 2.442) | 0.630 |
Imaging | ||||||
Infarct volume (cm3), mean (±SD) | 54.0 (±14.3) | 55.5 (±13.0) | 51.9 (±15.9) | 1.019 | (0.981, 1.059) | 0.331 |
Brainstem infarction, n (%) | 21 (36.2%) | 18 (52.9%) | 3 (12.5%) | 7.875 | (1.972, 31.444) | 0.003 |
Basilar artery occlusion | 10 (17.2%) | 8 (23.5%) | 2 (8.3%) | 3.385 | (0.650, 17.628) | 0.148 |
Vascular territory, n (%) | ||||||
PICA | 39 (67.2%) | 20 (58.8%) | 19 (79.2%) | 0.376 | (0.113, 1.247) | 0.110 |
SCA | 4 (6.9%) | 4 (11.8%) | 0 | * | * | 0.999 |
AICA | 0 | |||||
Multiple different territories | 15 (25.9%) | 10 (29.4%) | 5 (20.8%) | 1.583 | (0.462, 5.421) | 0.464 |
Side of the cerebellum | ||||||
Bilateral | 19 (32.8%) | 12 (35.3%) | 7 (29.2%) | 1.325 | (0.429, 4.087) | 0.625 |
Left | 19 (32.8%) | 10 (29.4%) | 9 (37.5%) | 0.694 | (0.229, 2.102) | 0.519 |
Right | 20 (34.5%) | 12 (35.3%) | 8 (33.3%) | 1.091 | (0.362, 3.285) | 0.877 |
Therapy | ||||||
Operation duration (minutes), mean (±SD) | 124 (±44.1) | 121 (±44.3) | 128 (±44.4) | 0.996 | (0.984, 1.008) | 0.528 |
Time between symptom onset and surgery (days), median (range) | 2 (1–10) | 2 (1–9) | 2 (1–10) | 0.922 | (0.691, 1.231) | 0.581 |
Time between malignant swelling and surgery (hours), median (range) | 6 (1–34) | 7 (1–34) | 5 (2–17) | 1.068 | (0.958, 1.190) | 0.234 |
EVD, n (%) | 46 (79.3%) | 30 (88.2%) | 16 (66.7%) | 3.750 | (0.977, 14.391) | 0.054 |
Intravenous tPA, n (%) | 9 (15.5%) | 4 (11.8%) | 5 (20.8%) | 0.507 | (0.121, 2.128) | 0.353 |
EVT, n (%) | 9 (15.5%) | 7 (20.6%) | 2 (8.3%) | 2.852 | (0.537, 15.138) | 0.219 |
Most common complications | ||||||
Aspiration pneumonia | 22 (37.9%) | 15 (44.1%) | 7 (29.2%) | 1.917 | (0.632, 5.820) | 0.251 |
Urinary tract infection | 15 (25.9%) | 10 (29.4%) | 5 (20.8%) | 1.583 | (0.462, 5.421) | 0.464 |
Hyperactive delirium | 8 (13.8%) | 1 (2.9%) | 7 (29.2%) | 0.074 | (0.008, 0.648) | 0.019 |
Odds Ratio | 95% CI for OR | p-Value | |
---|---|---|---|
Premorbid mRS | 2.715 | (1.166, 6.323) | 0.021 |
NIHSS on admission | 1.088 | (1.014, 1.168) | 0.019 |
Brainstem infarction | 7.035 | (1.255, 39.424) | 0.027 |
Hyperactive delirium | 0.020 | (0.001, 0.623) | 0.026 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Baki, E.; Baumgart, L.; Kehl, V.; Hess, F.; Wolff, A.W.; Wagner, A.; Hernandez Petzsche, M.R.; Boeckh-Behrens, T.; Hemmer, B.; Meyer, B.; et al. Functional Outcomes After Decompressive Surgery in Patients with Malignant Space-Occupying Cerebellar Infarction. Neurol. Int. 2024, 16, 1239-1246. https://doi.org/10.3390/neurolint16060094
Baki E, Baumgart L, Kehl V, Hess F, Wolff AW, Wagner A, Hernandez Petzsche MR, Boeckh-Behrens T, Hemmer B, Meyer B, et al. Functional Outcomes After Decompressive Surgery in Patients with Malignant Space-Occupying Cerebellar Infarction. Neurology International. 2024; 16(6):1239-1246. https://doi.org/10.3390/neurolint16060094
Chicago/Turabian StyleBaki, Enayatullah, Lea Baumgart, Victoria Kehl, Felix Hess, Andreas Wolfgang Wolff, Arthur Wagner, Moritz Roman Hernandez Petzsche, Tobias Boeckh-Behrens, Bernhard Hemmer, Bernhard Meyer, and et al. 2024. "Functional Outcomes After Decompressive Surgery in Patients with Malignant Space-Occupying Cerebellar Infarction" Neurology International 16, no. 6: 1239-1246. https://doi.org/10.3390/neurolint16060094
APA StyleBaki, E., Baumgart, L., Kehl, V., Hess, F., Wolff, A. W., Wagner, A., Hernandez Petzsche, M. R., Boeckh-Behrens, T., Hemmer, B., Meyer, B., Gempt, J., & Wunderlich, S. (2024). Functional Outcomes After Decompressive Surgery in Patients with Malignant Space-Occupying Cerebellar Infarction. Neurology International, 16(6), 1239-1246. https://doi.org/10.3390/neurolint16060094